SLC14A2: A Key Regulator of Intracellular Signaling Pathways (G8170)

Target Name: SLC14A2

NCBI ID: G8170

SLC14A2

SLC14A2: A Key Regulator of Intracellular Signaling Pathways

SLC14A2, also known as Transient receptor potential cation channel subfamily 14 member 2, is a protein that is expressed in many different tissues throughout the body. It is a member of the Solute carrier family 14, which is a large family of transmembrane proteins that play important roles in various physiological processes. SLC14A2 is primarily expressed in the brain, but it is also found in other tissues such as the heart, skeletal muscles, and red blood cells.

The SLC14A2 protein is known for its role in the regulation of intracellular signaling pathways. Specifically, it is involved in the intracellular signaling pathway known as the renin-angiotensin-aldosterone system (RAAS), which plays a critical role in regulating blood pressure and fluid balance in the body.

The RAAS is a complex system that is composed of several proteins, including the angiotensin receptor 2 (AR2), the angiotensin-converting enzyme (ACE), and the protein SLC14A2. SLC14A2 is one of the proteins that is associated with the RAAS.

SLC14A2 is a key regulator of the RAAS. It is known to interact with the angiotensin receptor 2 (AR2), which is a protein that is expressed in many different tissues throughout the body. The interaction between SLC14A2 and AR2 is critical for the regulation of the RAAS.

SLC14A2 is also involved in the regulation of the production of angiotensin II, a hormone that plays a critical role in the RAAS. Angiotensin II is produced by the liver in response to the presence of angiotensin I, a hormone that is produced by theRAAS. SLC14A2 is known to interact with the enzyme ACE, which is responsible for the production of angiotensin II.

In addition to its role in the RAAS, SLC14A2 is also involved in the regulation of various other cellular processes that are important for the survival and function of cells. For example, SLC14A2 is known to interact with the protein casein, which is a protein that is found in many different tissues throughout the body. The interaction between SLC14A2 and casein is critical for the regulation of the growth and survival of cells.

SLC14A2 is also involved in the regulation of the production of various signaling molecules that are important for the survival and function of cells. For example, SLC14A2 is known to interact with the protein tyrosine kinase (TK), which is a protein that is involved in the regulation of many different cellular processes. The interaction between SLC14A2 and TK is critical for the regulation of the production of signaling molecules that are important for the survival and function of cells.

In conclusion, SLC14A2 is a protein that is involved in the regulation of various cellular processes that are important for the survival and function of cells. Its role in the intracellular signaling pathway known as the RAAS and its interaction with the angiotensin receptor 2 (AR2) and the enzyme ACE are just a few examples of its involvement in cellular signaling. SLC14A2 is also involved in the regulation of the production of angiotensin II and various signaling molecules that are important for the survival and function of cells. As a drug target or biomarker, SLC14A2 may be a useful target for the development of new treatments for a variety of diseases.

Protein Name: Solute Carrier Family 14 Member 2

Functions: Mediates the transport of urea driven by a concentration gradient across the cell membrane of the renal inner medullary collecting duct which is critical to the urinary concentrating mechanism

The "SLC14A2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC14A2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets